Immunoprecise Antibodies
25 hedge funds and large institutions have $3M invested in Immunoprecise Antibodies in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 0 closing their positions.
Holders
25
Holders Change
+5
Holders Change %
+25%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
3
Closed
–
Calls
$600K
Puts
$26K
Net Calls
+$574K
Net Calls Change
+$1K
Top Buyers
| 1 |
ISL
1
Ingalls & Snyder LLC
New York
|
$2.19M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$128K |
| 3 |
3
Northern Trust
Chicago,
Illinois
|
$104K |
| 4 |
4
Squarepoint
New York
|
$82K |
| 5 |
5
Morgan Stanley
New York
|
$36K |
Top Sellers
| 1 |
1
Bank of Montreal
Toronto,
Ontario, Canada
|
$82.7K |
| 2 |
2
Dimensional Fund Advisors
Austin,
Texas
|
$20.9K |
| 3 |
3
CIBC World Market
Toronto,
Ontario, Canada
|
$70K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|
|
CFGS
27
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|